Infusion Time Differences and Patient Satisfaction with Intravenous Immunoglobulin(IVIg)for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Japan.(Time to Motion study)
Latest Information Update: 04 Aug 2022
At a glance
- Drugs Immune globulin (Primary)
- Indications Chronic inflammatory demyelinating polyradiculoneuropathy
- Focus Therapeutic Use
- Sponsors CSL Behring
- 20 Jul 2022 Status changed from active, no longer recruiting to completed.
- 23 Dec 2021 Planned End Date changed from 30 Sep 2021 to 30 Nov 2021.
- 23 Dec 2021 Status has been changed to active, no longer recruiting.